Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Intervalo de año de publicación
1.
Mol Biol Rep ; 46(1): 191-198, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30421128

RESUMEN

Cell transplantation offers a promising approach in many neurological disorders. Neural stem (NS) cells are potential candidates for cell therapy. The ability to track the grafted cells in the host tissue will refine this therapy. Superparamagnetic iron oxide nanoparticles (SPION) have been suggested as a feasible method, but there is no consensus about its safety. Here we investigated the feasibility of label NS cells with SPION and track by MRI after transplantation into mouse striatum with SPION cells and its therapeutic effects by grafting the cells into mouse striatum. We demonstrated that SPION-labeled NS cells display normal patterns of cellular processes including proliferation, migration, differentiation and neurosphere formation. Transmission electron microscopy reveals SPION in the cytoplasm of the cells, which was confirmed by microanalysis. Neurons and astrocytes generated from SPION-labeled NS cells were able to carry nanoparticles after 7 days under differentiation. SPION-labeled NS cells transplanted into striatum of mice were detected by magnetic resonance imaging (MRI) and microscopy 51 days later. In agreement with others reports, we demonstrated that NS cells are able to incorporate SPION in vitro without altering the stemness, and can survive and be tracked by MRI after they have been grafted into mice striatum.


Asunto(s)
Rastreo Celular/métodos , Nanopartículas de Magnetita/química , Células-Madre Neurales/fisiología , Animales , Diferenciación Celular , Supervivencia Celular , Células Cultivadas , Compuestos Férricos/metabolismo , Hierro/metabolismo , Imagen por Resonancia Magnética/métodos , Ratones , Microscopía Electrónica de Transmisión/métodos , Células-Madre Neurales/citología , Neuronas/fisiología
2.
Cell Biol Int ; 39(1): 121-7, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25045067

RESUMEN

Embryonic stem cells (ES cells) express a transient and heterogeneous pattern of molecules, which suggests a notable mechanism to control self-renewal avoid the differentiation into germ layers. We show that 9-O-acetyl GD3 (9OacGD3), a highly expressed b-series ganglioside in neural stem (NS) cells, is expressed in undifferentiated mouse ES cells in a heterogeneous fashion. After sorting, undifferentiated 9OacGD3(+) ES cell population had higher levels of nestin and Sox2 mRNA than the 9OacGD3(-) cells. Even with elevated expression of these neural transcription factors, 9OacGD3(+) cells did not give rise to more neural progenitors than 9OacGD3(-) cells. Expression of 9OacGD3 was recovered from 9OacGD3(-) cell population, demonstrating that expression of this ganglioside in mouse embryonic stem cells is transient, and does not reflect cell fate. Our findings show that the ganglioside 9OacGD3 is expressed heterogeneously and transiently in ES cells, and this expression corresponds to higher levels of Sox2 and Nestin transcripts.


Asunto(s)
Células Madre Embrionarias/metabolismo , Gangliósidos/genética , Regulación del Desarrollo de la Expresión Génica , Animales , Diferenciación Celular , Células Cultivadas , Células Madre Embrionarias/citología , Gangliósidos/metabolismo , Ratones , Nestina/genética , Nestina/metabolismo , Células-Madre Neurales/citología , Células-Madre Neurales/metabolismo , ARN Mensajero/metabolismo , Factores de Transcripción SOXB1/genética , Factores de Transcripción SOXB1/metabolismo
3.
Cell Transplant ; 21(10): 2215-24, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22776164

RESUMEN

Induced pluripotent stem cells (iPSCs) were originally generated by forced ectopic expression of four transcription factors genes-OCT4, KLF4, SOX2, and c-MYC-in fibroblasts. However, the efficiency of iPSCs obtention is extremely low, and reprogramming takes about 20 days. We reasoned that adult cells showing basal expression of core embryonic stem (ES) cell regulator genes could be a better cell source for reprogramming. Menstrual blood-derived mesenchymal cells (MBMCs) are multipotent cells that show detectable levels of some of the core ES cells regulators. The aim of this study was to determine whether reprogramming efficiency could be increased by using MBMCs as a cell source to generate iPSCs. MBMCs were transduced with recombinant retroviruses expressing the coding regions of OCT4, SOX2, and KLF4 genes. Cells with high nucleus/cytoplasm ratio can be detected about 5 days of posttransduction, and colonies of typical ES-like cells begun to appear after 7 days. At day 15, colonies were picked up and expanded for characterization. Most of the clones were morphologically identical to ES cells and positive at the mRNA and protein levels for all pluripotency markers tested. The clones are capable of forming embryoid bodies and to differentiate in vitro into cells of the three germ cell layers. Our results show that the reprogramming was faster and with efficiency around 2-5%, even in the absence of ectopic expression of c-MYC. To date, this is the first study showing MBMCs as a cell source for nuclear reprogramming.


Asunto(s)
Células Sanguíneas/fisiología , Reprogramación Celular/fisiología , Células Madre Pluripotentes Inducidas/fisiología , Menstruación/sangre , Células Madre Mesenquimatosas/fisiología , Células Sanguíneas/citología , Células Sanguíneas/metabolismo , Técnicas de Cultivo de Célula/métodos , Diferenciación Celular/fisiología , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Células Madre Pluripotentes Inducidas/citología , Células Madre Pluripotentes Inducidas/metabolismo , Factor 4 Similar a Kruppel , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/metabolismo
4.
Stem Cell Res ; 9(2): 143-55, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22742973

RESUMEN

Bone marrow mesenchymal stem cells (MSC) have been tested and proven effective in some neurodegenerative diseases, but their tracking after transplantation may be challenging. Our group has previously demonstrated the feasibility and biosafety of rat MSC labeling with iron oxide superparamagnetic nanoparticles (SPION). In this study, we investigated the therapeutic potential of SPION-labeled MSC in a rat model of Huntington's disease, a genetic degenerative disease with characteristic deletion of striatal GABAergic neurons. MSC labeled with SPION were injected into the striatum 1h after quinolinic acid injection. FJ-C analysis demonstrated that MSC transplantation significantly decreased the number of degenerating neurons in the damaged striatum 7 days after lesion. In this period, MSC transplantation enhanced the striatal expression of FGF-2 but did not affect subventricular zone proliferation, as demonstrated by Ki67 proliferation assay. In addition, MSC transplantation significantly reduced the ventriculomegaly in the lesioned brain. MRI and histological techniques detected the presence of the SPION-labeled cells at the lesion site. SPION-labeled MSC produced magnetic resonance imaging (MRI) signals that were visible for at least 60 days after transplantation. Our data highlight the potential of adult MSC to reduce brain damage under neurodegenerative diseases and indicate the use of nanoparticles in cell tracking, supporting their potential as valuable tools for cell therapy.


Asunto(s)
Dextranos/uso terapéutico , Enfermedad de Huntington/terapia , Imagen por Resonancia Magnética/métodos , Nanopartículas de Magnetita/uso terapéutico , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/metabolismo , Nanopartículas/uso terapéutico , Fármacos Neuroprotectores/farmacología , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Ferrocianuros/metabolismo , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Enfermedad de Huntington/patología , Masculino , Células Madre Mesenquimatosas/citología , Neostriado/efectos de los fármacos , Neostriado/patología , Degeneración Nerviosa/patología , Degeneración Nerviosa/terapia , Ratas , Ratas Wistar , Coloración y Etiquetado
5.
Biochem Biophys Res Commun ; 419(1): 38-42, 2012 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-22326867

RESUMEN

The protozoan parasite Trypanosoma cruzi, the etiological agent of Chagas Disease, undergoes through a complex life cycle where rounds of cell division and differentiation occur initially in the gut of triatominae vectors and, after transmission, inside of infected cells in vertebrate hosts. Members of the Ras superfamily of GTPases are molecular switches which play pivotal regulatory functions in cell growth and differentiation. We have previously described a novel GTPase in T. cruzi, TcRjl, which belongs to the RJL family of Ras-related GTP binding proteins. Here we show that most of TcRjl protein is found bound to GTP nucleotides and may be locked in this stage. In addition, we show that TcRjl is located close to the kinetoplast, in a region corresponding possibly to flagellar pocket of the parasite and the expression of a dominant-negative TcRjl construct (TcRjlS37N) displays a significative growth phenotype in reduced serum medium. Remarkably, overexpression of TcRjl inhibits differentiation of epimastigotes to trypomastigote forms and promotes the accumulation of intermediate differentiation stages. Our data suggest that TcRjl might play a role in the control of the parasite growth and differentiation.


Asunto(s)
Diferenciación Celular , Proliferación Celular , Proteínas de Unión al GTP Monoméricas/metabolismo , Trypanosoma cruzi/crecimiento & desarrollo , Guanosina Trifosfato/química , Guanosina Trifosfato/metabolismo , Interacciones Huésped-Parásitos , Humanos , Proteínas de Unión al GTP Monoméricas/química , Proteínas de Unión al GTP Monoméricas/genética , Trypanosoma cruzi/citología , Trypanosoma cruzi/enzimología
6.
Stem Cells Dev ; 20(11): 1859-72, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21417836

RESUMEN

Glycosylated mouse cystatin C (mCysC), an endogenous inhibitor of cysteine cathepsin proteases (CP), has been suggested as a cofactor of ß-FGF to induce the differentiation of mouse embryonic stem cells into neural progenitor cells (NPCs). To investigate the possible role of CP in neural differentiation, we treated embryoid bodies (EBs) with (i) E64, an inhibitor of papain-like CP and of calpains, (ii) an inhibitor of cathepsin L (iCatL), (iii) an inhibitor of calpains (iCalp), or (iv) cystatins, and their ability to differentiate into neural cells was assessed. We show that the inhibition of CP induces a significant increase in Pax6 expression in EBs, leading to an increase in the number of nestin-positive cells after 3 days. Fourteen days after E64 treatment, we observed increased numbers of ß-III-tubulin-positive cells, showing greater percentage of immature neurons, and this feature persisted up to 24 days. At this point, we encountered higher numbers of neurons with inward Na(+) current compared with untreated EBs. Further, we show that mCysC and iCatL, but not unglycosylated egg white cystatin or iCalp, increased the numbers of NPCs. In contrast to E64 and iCatL, mCysC did not inhibit CP in EBs and its neural-inducing activity required ß-FGF. We propose that the inhibition of CP induces the differentiation of mouse embryonic stem cells into NPCs and neurons through a mechanism that is distinct from CysC-induced neural differentiation.


Asunto(s)
Catepsina L/antagonistas & inhibidores , Diferenciación Celular , Cistatina C/fisiología , Células Madre Embrionarias/fisiología , Animales , Antígenos de Diferenciación/genética , Antígenos de Diferenciación/metabolismo , Calpaína/antagonistas & inhibidores , Catepsina L/metabolismo , Línea Celular , Extensiones de la Superficie Celular/metabolismo , Técnicas de Cocultivo , Cistatina C/metabolismo , Cistatina C/farmacología , Inhibidores de Cisteína Proteinasa/farmacología , Proteínas de Unión al ADN , Cuerpos Embrioides/citología , Cuerpos Embrioides/efectos de los fármacos , Cuerpos Embrioides/enzimología , Células Madre Embrionarias/efectos de los fármacos , Células Madre Embrionarias/enzimología , Proteínas del Ojo/metabolismo , Proteína GAP-43/genética , Proteína GAP-43/metabolismo , Expresión Génica , Proteínas de Homeodominio/metabolismo , Humanos , Proteínas de Filamentos Intermediarios/genética , Proteínas de Filamentos Intermediarios/metabolismo , Leucina/análogos & derivados , Leucina/farmacología , Potenciales de la Membrana , Ratones , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Nestina , Proteínas de Neurofilamentos/metabolismo , Neuronas/efectos de los fármacos , Neuronas/enzimología , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Factor de Transcripción PAX6 , Factores de Transcripción Paired Box/metabolismo , Proteínas Represoras/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...